Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light
Phase 2
Withdrawn
- Conditions
- Esophageal CancerHigh-grade Dysplasia in Barrett EsophagusNon Small Cell Lung Cancer
- Interventions
- Drug: Solar Protection Formula SPF® 60Procedure: Photobiological testing
- First Posted Date
- 2010-12-08
- Last Posted Date
- 2014-03-04
- Lead Sponsor
- Pinnacle Biologics Inc.
- Registration Number
- NCT01256203
Safety of Photodynamic Therapy (PDT) in the Ablation of High-grade Dysplasia (HGD) in Barrett's Esophagus (BE)
Phase 3
Withdrawn
- Conditions
- Barrett Esophagus
- First Posted Date
- 2010-09-24
- Last Posted Date
- 2012-05-08
- Lead Sponsor
- Pinnacle Biologics Inc.
- Registration Number
- NCT01209013
Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety Outcomes
Withdrawn
- Conditions
- Esophageal CancerLung CancerBarrett's Esophagus
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2012-05-09
- Lead Sponsor
- Pinnacle Biologics Inc.
- Registration Number
- NCT01203163
News
No news found